Operating Expenses 更改
AbbVie USD 9.35B 1.76B 2024-03
Amgen USD 6.46B 469M 2024-03
AstraZeneca USD 9.56B 1.23B 2024-03
Bausch Health Companies USD 1.86B 186M 2024-03
Biogen USD 1.72B 306.9M 2024-03
Bristol-Myers Squibb USD 10.35B 728M 2024-03
Canopy Growth CAD 105.6M 33.79M 2024-03
Catalent USD 1.09B 45M 2024-03
Corcept Therapeutics USD 117.31M 13.57M 2024-03
Drreddys Laboratories INR 54.88B 3.95B 2023-12
Eli Lilly USD 6.03B 933.2M 2024-03
Gilead Sciences USD 6.88B 1.37B 2024-03
GlaxoSmithKline GBP 5.87B 1.61B 2024-03
Glaxosmithkline GBP 5.87B 1.61B 2024-03
J&J USD 15.11B 1.46B 2024-03
Merck USD 10.02B 6.55B 2024-03
Novartis USD 8.75B 447M 2024-03
Novartis USD 8.75B 447M 2024-03
Pacira USD 152M 3.93M 2024-03
Perrigo USD 1.09B 76.3M 2024-03
Pfizer USD 10.68B 10.12B 2024-03
Prestige Brands USD 194.84M 1.07M 2024-03
Roche Holding CHF 20.02B 5.04B 2023-06
Sanofi EUR 8.89B 600M 2024-03
Sanofi EUR 8.89B 600M 2024-03
Supernus Pharmaceuticals USD 147.89M 17.42M 2024-03
Zoetis USD 1.39B 174M 2024-03



Novartis 营业费用 - 当前值,历史数据,预测,统计,图表和经济日历 - Jun 2024.